Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianyu Shao

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Acta Pharmaceutica Sinica. B|May 15, 2025
Engineered bacteria assist CAR-cell immunotherapyTianyu Shao, Manman Xu, Jie Li, et al.
Heliyon|July 17, 2024
Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based studyJiaping Liu, Yu Cao, Tianyu Shao, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 19, 2026
Beyond race: The need for multidimensional analysis in IPAA outcomesXimeng Ren, Yao Song, Meng Li, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 2025
Retraction notice to "Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysis". [Lung Cancer 204 (2025) 108559]Tianyu Shao, Jiayao Yang, Jialu Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2025
Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysisTianyu Shao, Jiayao Yang, Jialu Chen, et al.
Scientific Reports|March 4, 2022
Prognostic nomograms for predicting overall survival and cancer-specific survival in patients with angiosarcoma, a SEER population-based studyTing Jiang, Zixiang Ye, Tianyu Shao, et al.
Integrative Cancer Therapies|April 21, 2023
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical TrialLiumei Shou, Tianyu Shao, Jialu Chen, et al.
Pharmacogenomics|November 16, 2022
Capecitabine-induced enterocolitis: a case report and pharmacogenetic profileTianyu Shao, Yao Zhang, Jiaping Liu, et al.
Human Vaccines & Immunotherapeutics|February 13, 2024
Exploration of genetic characterization in hyperprogressive disease after immunotherapy retreatment in a patient with LCNEC: A case reportYao Zhang, Jiayao Yang, Tianyu Shao, et al.
Frontiers in Neurology|September 12, 2022
Effectiveness of gastrodin for migraine: A meta-analysisXiu Zhou, Jingyi Shao, Xiuzhen Xie, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Acta Pharmaceutica Sinica. B|May 15, 2025
Engineered bacteria assist CAR-cell immunotherapyTianyu Shao, Manman Xu, Jie Li, et al.
Heliyon|July 17, 2024
Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based studyJiaping Liu, Yu Cao, Tianyu Shao, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 19, 2026
Beyond race: The need for multidimensional analysis in IPAA outcomesXimeng Ren, Yao Song, Meng Li, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 2025
Retraction notice to "Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysis". [Lung Cancer 204 (2025) 108559]Tianyu Shao, Jiayao Yang, Jialu Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2025
Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysisTianyu Shao, Jiayao Yang, Jialu Chen, et al.
Scientific Reports|March 4, 2022
Prognostic nomograms for predicting overall survival and cancer-specific survival in patients with angiosarcoma, a SEER population-based studyTing Jiang, Zixiang Ye, Tianyu Shao, et al.
Integrative Cancer Therapies|April 21, 2023
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical TrialLiumei Shou, Tianyu Shao, Jialu Chen, et al.
Pharmacogenomics|November 16, 2022
Capecitabine-induced enterocolitis: a case report and pharmacogenetic profileTianyu Shao, Yao Zhang, Jiaping Liu, et al.
Human Vaccines & Immunotherapeutics|February 13, 2024
Exploration of genetic characterization in hyperprogressive disease after immunotherapy retreatment in a patient with LCNEC: A case reportYao Zhang, Jiayao Yang, Tianyu Shao, et al.
Frontiers in Neurology|September 12, 2022
Effectiveness of gastrodin for migraine: A meta-analysisXiu Zhou, Jingyi Shao, Xiuzhen Xie, et al.
Pageof 4